Founded Date: 01 01 13
Technology: Neurological Disorders
Investor Type: Company
Funding Status: IPO
Total Funding: 135000000
Employee Number: 101-250
Headquarters: Cambridge, Massachusetts, United States
Last Funding Date: 13 04 15
Investors Number: 7
Last Funding Type: Series B
Estimated Revenue: $10M to $50M
Investment Stage: N/A
Number Of Exists: Series B
Industry: Biotechnology, Health Care, Science and Engineering